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Hydrogels are biomaterials widely used 
for tissue repair in tissue engineering. 
With their biocompatibility and tunable 
architecture, hydrogels can simulate the 
physical structure of the extracellular 
matrix to promote cell proliferation and 
tissue regeneration.[1–3] Hydrogels are 
able to encapsulate and deliver different 
drugs for various kinds of tissue repair 
processes, for example, flap regeneration, 
skin healing, and bone reconstruction.[4–6] 
Injured tissue repair is a dynamic and 
complex process. During the early stage 
of skin flap recovery, tissue suffers from 
damaged homeostasis and cell apoptosis 
caused by inflammation, ischemia, and 
hypoxia; then, in the proliferation period, 
the cells proliferate rapidly after endothe-
lial cells exhibit adequate vascularization, 
while fibroblasts and mesenchymal stem 
cells help with healing and regeneration. 
Finally, during the remodeling period, the 
tissue undergoes structure and vascular 
network remodeling and maturing, which 
take months or years to for the tissue to 
eventually regain its normal function.[7,8] 
The fabrication of highly biocompatible hydrogels with multiple unique 
healing abilities for the whole healing process, for example, multifunctional 
hydrogels with injectable, degradation, antibacterial, antihypoxic, and wound 
healing–promoting properties that match the dynamic healing process of skin 
flap regeneration, is currently a research challenge. Here, a multifunctional 
and dynamic coordinative polyethylene glycol (PEG) hydrogel with mangif-
erin liposomes (MF-Lip@PEG) is developed for clinical applications through 
Ag–S coordination of four-arm-PEG-SH and Ag+. Compared to MF-PEG, 
MF-Lip@PEG exhibits self-healing properties, lower swelling percentages, 
and a longer endurance period. Moreover, the hydrogel exhibits excellent 
drug dispersibility and release characteristics for slow and persistent drug 
delivery. In vitro studies show that the hydrogel is biocompatible and nontoxic 
to cells, and exerts an outstanding neovascularization-promoting effect. The 
MF-Lip@PEG also exhibits a strong cytoprotective effect against hypoxia-
induced apoptosis through regulation of the Bax/Bcl-2/caspase-3 pathway. 
In a random skin flap animal model, the MF-Lip@PEG is injectable and 
convenient to deliver into the skin flap, providing excellent anti-inflammation, 
anti-infection, and proneovascularization effects and significantly reducing 
the skin flap necrosis rate. In general, the MF-Lip@PEG possesses out-
standing multifunctionality for the dynamic healing process of skin flap 
regeneration.
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However, little research has been done to optimize hydro-
gels’ drug releasing and degradation property to match with 
each dynamic healing process. Therefore, multifunctionalized 
hydrogels that could synchronize with tissue physiological 
healing process would have significant potential in bioengi-
neering applications.
For example, in the early stage of random skin flap recon-
struction, deprivation of adequate blood supply causes flap 
hypoxia, ischemia/reperfusion, and inflammation, especially in 
the distal part. The unfavorable hypoxic environment hinders 
flap rapid regeneration during the early stages. To address this 
problem, previous studies mainly focus on using hydrogels as 
various drugs and cytokine delivery systems to reduce distal end 
necrosis in the skin flap. However, using cytokines to stimulate 
angiogenesis does not protect cells from hypoxia, high concen-
trations of cytokines and drugs can cause side effects and even 
impair healing.[9–11] Moreover, in these studies, the hydrogels 
only act as physical supports to deliver cargos, and thus, the 
healing effect of these hydrogels is not an area of concern.[12]
Hydrogels can be modified to improve their performance in 
tissue engineering, including cell proliferation, new microvas-
cular network formation, and tissue extracellular matrix struc-
ture construction.[13,14] Although many studies have focused 
on the chemical and physical internal structure of hydrogels, 
the healing improvement capacity of hydrogels themselves 
has received little attention.[15] Hydrogels delivered to the 
wound area during the tissue healing process can directly con-
tact and interact with the wounded cells. The hydrogel’s drug 
releasing and degradation property could be modified to match 
with the dynamic healing process.[16] Herein, we investigate 
the biological repair and healing effect of hydrogels with the 
goal to uncover its role and mechanisms in tissue repair and 
regeneration.
In this work, we crosslinked four-armed polyethylene glycol 
(PEG) with Ag+ by Ag–S coordination to form a dynamic coor-
dinative and injectable PEG-Ag hydrogel that was loaded with 
mangiferin liposomes (MF-Lip) to promote skin flap survival 
rate through the combination of the cytoprotective effect of 
mangiferin and sustained anti-infection and accelerated wound 
healing activity of Ag+ under hypoxic conditions.[17] The dynamic 
coordinative PEG hydrogel constructed by Ag–S coordination 
exhibited outstanding injectable, self-healing, degradable, and 
anti-infection properties. In addition, mangiferin (MF), a natu-
rally occurring glucosyl xanthone commonly found in mango 
and papaya, has been suggested to possess various pharmaco-
logical activities, such as antioxidant, anti-inflammatory, antia-
poptotic, and immunomodulation effects.[18–21] Herein, we 
fabricated a hydrogel that is able to locally release Ag+ and MF 
and that exhibit anti-infection, cytoprotective, and angiogenesis 
activity under hypoxic conditions. The hydrogel delivery system 
slowly degrades with the skin flap healing process while guar-
anteeing enough mangiferin concentration in situ to promote 
skin flap regeneration. With the combination of cytoprotec-
tive and angiogenesis of mangiferin and the anti-infection and 
healing promotion ability of Ag+, the hydrogel delivery system is 
expected to match the renewal of random skin flap regeneration 
progress and promote skin flap survival. (Scheme 1).
MF was loaded in the lipid bilayer of liposomes, which 
consists of phosphatidylcholine and cholesterol (Figure S1, 
Supporting Information). The morphology of the MF-Lip 
was investigated by transmission electron microscopy (TEM) 
(Figure S2, Supporting Information) and scanning elec-
tron microscopy (SEM) (Figure S3, Supporting Informa-
tion). According to these images, the nanoparticles showed a 
bilayer structure; specifically, the darker parts were the inner 
water phase of the liposomes, and the lighter parts indicated 
the lipid bilayer. For the surface properties, lyophilized lipo-
some powder with a round smooth surface was observed, as 
shown in Figure S3 in the Supporting Information. To fur-
ther characterize the MF liposomes, their size distribution 
and polydispersity index (PDI) were investigated (Figure S4, 
Supporting Information): the average size of the MF-Lip was 
142.7 ± 2.4 nm, and the PDI was 0.140 ± 0.023. Moreover, 
the zeta potential distribution is shown in Figure S5 in the 
Supporting Information, and the mean zeta potential was 
−8.57 ± 1.11 mV. The entrapment efficiency of these liposomes 
was 66.7 ± 3.2% and the drug release in vitro lasted for almost 
24 h, with the cumulative percent release reaching over 75% 
(Figure S6, Supporting Information).
To explore the process of gelation (Figure 1a,b), it was 
observed that before mixing the solution of four-arm PEG-
thiol with AgNO3, the solution of the materials had excellent 
flowability. After mixing these two solutions, a composite gel 
containing MF-Lip was formed. Furthermore, the injection 
capability of the gel was confirmed, as shown in Figure 1c. 
The rhodamine-dyed MF-Lip@PEG was continuously injected 
though the syringe with a 0.5 mm needle. The hydrogels were 
also injected into a centrifuge tube filled with deionized (DI) 
water to prove that they can not only be injected but also main-
tain their shape in solution, as shown in Figure 1d−f. The sur-
face structure of the hydrogel was observed by SEM at 1 h, as 
shown in Figure S7 in the Supporting Information. At low 
magnification, there were no significant differences among 
these diverse groups from PEG to MF-Lip40@PEG (Figure S7, 
Supporting Information). In contrast, some nanoparticles were 
observed on the surface of the MF-Lip@PEG with different con-
centrations of MF-Lip under high magnification; particularly, 
increasing amounts of MF-Lip led to an increase in the number 
of nanoparticles on the surface of the composite hydrogels. Fur-
thermore, the magnified SEM images also showed a successful 
combination between the MF-Lip and the PEG hydrogel.
Before considering its drug-carrying capabilities, the 
hydrogel has to be able in exhibit self-healing properties and 
endure external strain. As shown in Figure 1i, both the elastic 
modulus (G’) and loss modulus (G”) could withstand an 
increase in strain of ≈50%. Furthermore, upon examination of 
the recoverability by a rheometer, it was observed that before 
applying high shear rate, the hydrogel was able to maintain 
a colloidal state while keeping the viscosity at ≈7.5 × 105 Pas; 
then, when a high shear rate was applied, the hydrogel’s struc-
ture was destroyed, and the viscosity of the hydrogel dropped 
to almost 0.7 × 105 Pas. However, a few seconds after the high 
shear rate was removed, the hydrogel recovered to a state sim-
ilar to the one prior to being subjected to the external shear 
rate (Figure 1j). From a macro view, the same process was also 
observed in photographs (Figure 1k), where a hole was cre-
ated in the center of the hydrogel after ≈10 min, followed by 
recovery from the damage. The mechanism of the process is 
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described in Figure l. During the mixing of four-arm PEG-thiol 
with AgNO3, the covalent bonds formed between S and Ag, as 
well as the simultaneous formation of interactions between 
Ag and Ag, transformed the solution to the gel.[22,23] When 
an intense external shear rate was applied, these bonds were 
destroyed, and when these external forces were removed, the 
network regenerated. Therefore, we predicted at this point that 
the hydrogels were capable of recovery after injection.
Regarding implantation, a hydrogel should have the capa-
bility to not only maintain its integral construction during the 
treatment process, but also undergo degradation. As shown in 
Figure 1m, MF-Lip40@PEG showed the longest endurance 
period for 12 d compared to 9 d for both MF-Lip20@PEG and 
MF-Lip10@PEG, while the shortest time was 7 d for PEG. 
Regarding the swelling percentages, PEG exhibited the highest 
value (almost 1200%). In contrast, the swelling percentages in 
all MF-Lip@PEG groups were noticeably lower, ranging from 
≈900% for both MF-Lip20@PEG and MF-Lip10@PEG to just 
800% for MF-Lip40@PEG. Increasing amounts of MF-Lip 
were added to the hydrogel system, leading to a denser network 
structure in the composite hydrogels, and resulting in lower 
swelling percentages and longer endurance periods of the 
MF-Lip40@PEG, because the dense network could serve as a 
barrier to the movement of water molecules.[24,25]
MF is a hydrophobic drug and tends to aggregate upon direct 
blending with a solution of four-arm PEG-thiol and AgNO3. 
Thus, MF-PEG produced by this method showed poor drug dis-
persion, and the release percentage of MF from PEG-MF was the 
lowest (≈50%). Almost half of the loaded MF was not released 
from the MF-PEG because of severe aggregation of MF in the 
hydrogel matrix. In contrast, the liposomes were able to carry 
MF in their bilayer, leading to excellent dispersibility of the drug 
in the composite hydrogel networks. As a result, the cumula-
tive release percentages of MF were significantly improved from 
50% in MF-PEG to ≈95% in the three MF-Lip@PEG groups. 
Specifically, these drugs would be released in several methods 
in vitro. First, these drugs would be released from the bilayers 
with the leakage of liposome, and second, these drug-loaded 
liposomes would be released from the composite hydrogel, 
and then these drugs could be detected in the release medium. 
In particular, the MF-Lip40@PEG exhibited more favorable 
release characteristics than those of the other two MF-Lip@PEG 
Adv. Sci. 2019, 6, 1801555
Scheme 1. Schematic illustrations of MF-Lip@PEG matching the renewal of random skin flap regeneration. a) Four-arm-PEG-SH, MF and Ag+ constructed 
by Ag–S coordination form the dynamic coordinative hydrogel. b) MF-Lip@PEG was injected into the derma, and the MF-Lip was encapsulated in situ 
during the Ag–thiol coordination. The hydrogel continued to release MF-Lip and Ag+ while slowly degrading with the flap healing process. c) The 
MF-Lip@PEG promote skin flap survival rate through the combined cytoprotective, neovascularization-promoting, anti-inflammation, and antibacterial 
effects and the reduction in skin flap necrosis rate under hypoxic conditions, matching the renewal of flap regeneration.
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Figure 1. Related properties of MF-Lip, morphological examination of the hydrogels, and characterization of the hydrogels. a) Solution of four-arm 
PEG-thiol with MF-Lip. b) The MF-Lip@PEG hydrogel. c) Photograph of the injectable hydrogel. d–f) Images of a hydrogel injected into DI water. 
h) Magnified SEM results (liposomes are marked by yellow circles). i) Strain sweep measurements of the storage moduli (G’ denotes the elastic 
modulus, and G” denotes the loss modulus), measured in kPa, and their effect on the strain of the hydrogels (%), which was used to determine their 
tensile strength. j) Measure of viscosity parameters in relation to time in seconds. The strain shearing rate alternated between 0.05% strain for 100 s 
and 500% strain for 50 s. k) The process of self-healing. l) The mechanism of the self-healing ability and injectability. m) Degradation. n) Swelling 
percentage. o) In vitro drug release.
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groups, because the dense network is capable of making contri-
butions to sustain the in vitro drug release.[26,27]
The beneficial effects of MF-Lip@PEG were investigated 
in human endothelial vein cells (HUVECs), and the angio-
genic activity of the liposome was studied in vitro. HUVECs 
were treated with different concentrations of MF-Lip@PEG 
leaching liquor for 7 d, and the protein expression levels of 
vascular endothelial growth factor (VEGF) and basic fibroblast 
growth factor (bFGF) were identified by western blot analysis. 
As shown in Figure 2, at concentrations below 40 × 10−6 m, the 
MF-Lip40@PEG could significantly increase the expression 
level of VEGF and bFGF in a dose-dependent manner. Moreover, 
the expression level of VEGF and bFGF in the groups treated 
with MF-Lip10@PEG, MF-Lip20@PEG, and MF-Lip40@PEG 
was significantly higher than those in the control group. How-
ever, the promotion effect of MF-Lip60@PEG was dramatically 
decreased, similar to the results observed for MF’s effect on cell 
viability (Figures S8 and S9, Supporting Information). There-
fore, the concentrations of MF-Lip10@PEG, MF-Lip20@PEG, 
and MF-Lip40@PEG were chosen for further studies.
Endothelial cells are essential cells for blood vessels, and they 
play an important role in blood vessel formation.[28] The vascular 
endothelial cells can secrete a variety of vasoactive substances via 
autocrine and paracrine mechanisms.[29] A study reported that 
MF could increase endothelial cell migration in a dose-dependent 
manner, indicating that MF has beneficial effects on the forma-
tion of new blood vessels.[30] Angiogenesis is very important in 
the early stage of healing. VEGF and bFGF are growth factors 
that play a central role in angiogenesis by promoting neovascu-
larization and endothelial cell proliferation. A lack of these fac-
tors can result in abnormal vessel formation.[31,32] In the present 
study, we found that following treatment with MF-Lip@PEG 
leaching liquor for 7 d, the expression levels of VEGF and bFGF 
in HUVECs increased significantly in a dose-dependent manner 
at concentrations below 40 × 10−6 m (Figure 2b,c). The present 
results indicate that the MF-Lip@PEG leaching liquor could pro-
mote the cells’ angiogenesis ability.
As a result of the MF-Lip’s antiapoptotic effect, the 
MF-Lip@PEG was expected to have cell protection ability under 
hypoxic conditions. To investigate this effect, we stimulated a 
hypoxic environment in vitro. A hypoxic microenvironment for 
HUVECs was induced with 400 × 10−6 m CoCl2 (Figures S10 
and S11, Supporting Information). The HUVECs were fur-
ther treated with PEG, MF-Lip10@PEG, MF-Lip20@PEG, or 
MF-Lip40@PEG leaching liquor, and cell apoptosis was 
assessed by flow cytometry. In the hypoxia group, the cell apop-
tosis rate was 39.8 ± 4.5%. Significantly decreased cell apoptosis 
rates were observed in the MF-Lip@PEG leaching liquor-treated 
groups. Additionally, the apoptosis rate in the MF-Lip10@PEG 
group was 17.5 ± 2.1%, whereas that in the MF-Lip20@PEG 
group was 12.2 ± 2.0% and that in the MF-Lip40@PEG group 
was 10.0 ± 3.0%. In the MF-Lip@PEG leaching liquor groups, 
CoCl2-induced cell apoptosis was significantly inhibited in a 
dose-dependent manner. Significantly decreased cell apoptosis 
was observed in the MF-Lip@PEG-treated groups compared 
to the PEG-only group and the hypoxia group (Figure 2h−n), 
indicating that MF-Lip@PEG leaching liquor could ameliorate 
apoptosis in the hypoxia-induced cells. It is worth noting that 
the apoptosis rate in the PEG group was 27.3 ± 3.2%, which was 
also significantly lower than that in the hypoxia group, therefore 
suggesting that the PEG leaching liquor can also significantly 
inhibit 400 × 10−6m CoCl2-induced cell apoptosis.
It was observed that the MF-Lip@PEG was capable of 
attenuating CoCl2-induced cell apoptosis in HUVECs. We next 
sought to determine the underlying mechanisms by examining 
protein expression of the apoptosis-related proteins cleaved-cas-
pase-3 and Bax/Bcl-2. Treatment with MF-Lip@PEG leaching 
liquor significantly reduced the cells’ cleaved-caspase-3 expres-
sion levels in a dose-dependent manner (Figures 2d,g). Simi-
larly, the MF-Lip@PEG leaching liquor significantly reversed 
the CoCl2-induced expression of Bax/Bcl-2 (Figure 2d−f). The 
Bax/Bcl-2/caspase-3 pathway is very important in the process of 
apoptosis.[33] Bax is a proapoptotic protein that is polymerized 
after apoptotic provocation and generates pores in the mito-
chondrial membrane, subsequently inducing cell apoptosis.[34] 
Bcl-2 is a major antiapoptotic protein and can regulate apop-
tosis by binding to Bax and inhibit its apoptotic effect.[35] 
Therefore, the Bcl-2/Bax ratio is a crucial factor in cell survival. 
Members of the caspase family are essential proteins in cell 
apoptosis, among which caspase-3 is crucial effector during 
the apoptotic process.[36] The current study indicates that the 
MF-Lip@PEG can protect hypoxia-damaged HUVECs through 
regulation of the Bax/Bcl-2/caspase-3 pathway. Moreover, it was 
observed that PEG leaching liquor also protected the HUVECs 
from apoptosis and upregulated the Bcl-2/Bax ratio, suggesting 
that the PEG leaching liquor alone exerted a protective effect on 
the hypoxia-damaged HUVECs cells.
To further demonstrate the persistent skin flap regener-
ation-promoting capability of the hydrogel in vivo, the effect 
of the hydrogel on a random-pattern skin flap rat model was 
investigated. An ≈1.5 × 5 cm random skin flap was elevated 
on the dorsal side of the rats (Figure 3a), and the hydrogel 
was intradermally injected into the skin flap before the flap 
was put back in its original position (Figure 3b,c). Different 
concentrations of MF directly blended in the hydrogel for the 
skin flap treatment were also investigated (Figure S12, Sup-
porting Information). At 7 d after treatment, the rats were 
anesthetized, and the skin flap survival rates were assessed 
using a moorFLPI (Moor instruments, UK) to detect the real-
time flap blood flow. The contrast images obtained were color-
coded to correlate with blood flow of the flap (Figure 3e). The 
average necrosis rate in the control groups was ≈38.6 ± 1.25% 
(n = 6), while the average necrosis rate in the 40 × 10−6 m 
MF-Lip group was 23 ± 0.1% (n = 6) and the average necrosis 
rate in the PEG group was 28.4 ± 1.4% (n = 6). Lower skin 
flap necrosis rates were observed in flaps treated with the 
MF-Lip@PEG. For the MF-Lip10@PEG group, the average 
necrosis rate was 25.4 ± 2.3% (n = 6); for the MF-Lip20@PEG 
group, the average necrosis rate was 20.8 ± 0.8% (n = 6); and 
for the MF-Lip40@PEG group, the average necrosis rate was 
12.8 ± 1.2% (n = 6). It was observed that, without loading of 
the MF-Lip into the hydrogel, PEG alone could significantly 
increase the skin flap survival rate. Additionally, the skin flap 
survival rates further increased with the MF-Lip@PEG in a 
dose-dependent manner.
Skin flap angiogenesis was studied to further investi-
gate the neovascularization effect of the hydrogel on the skin 
flap. CD31 immunohistochemical staining was performed in 
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Figure 2. The effects of MF-Lip@PEG on HUVEC angiogenesis ability and the protective effect of MF-Lip@PEG on 400 × 10−6 m CoCl2-damaged 
HUVECs. a) Western blotting data showing the levels of angiogenesis-related growth factors with different MF treatments after 7 d. Western blotting 
data of the levels of b) VEGF and c) bFGF with different MF-Lip@PEG treatments after 7 d. d) Western blotting data showing the levels of apoptosis 
pathway-related protein expression with different treatments after 24 h. Western blotting data of the levels of e) Bax, f) Bcl-2, and g) cleaved-caspase 3 
with different MF-Lip@PEG treatments 24 h. h–n) Flow cytometric analysis of cell apoptosis after 24 h of treatment with 400 × 10−6 m CoCl2 and PEG 
or different concentrations of MF-Lip@PEG. Hypoxia: cells were treated with 400 × 10−6 m CoCl2 to stimulate hypoxia-induced damage and were not 
treated with MF-Lip@PEG; PEG: PEG leaching liquor; 10: MF-Lip10@PEG leaching liquor; 20: MF-Lip20@PEG leaching liquor; 40: MF-Lip40@PEG 
leaching liquor; 60: MF-Lip60@PEG leaching liquor. *p < 0.05.
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order to study the skin flap neovascularization. Cross-sections 
of the flap revealed that PEG and the MF-Lip@PEG signifi-
cantly increased the densities of the flap microvessels. After 
7 d, massive microvessels were seen in the PEG-treated groups 
(Figure 4a, the red dots marked the microvessels). The average 
microvessel densities were 20.2 ± 12.0 microvessels/spot in the 
control group; 45.0 ± 5.0 microvessels/spot in the 40 × 10−6 m 
MF-Lip group; 70.6 ± 5.0 microvessels/spot in the PEG group; 
42.0 ± 3.2 microvessels/spot in the MF-Lip10@PEG group; 
50.0 ± 5.5 microvessels/spot in the MF-Lip20@PEG group; and 
55.7 ± 4.2 microvessels/spot in the MF-Lip40@PEG group. The 
CD31 staining was significantly increased in the treatment groups, 
and there was no difference between the 40 × 10−6 m MF-Lip 
group and the MF-Lip40@PEG group (Figure 4c). Immunohis-
tochemical staining of CD31 proved the dose-dependent pro-
angiogenic effect of the MF-Lip@PEG. The microvessel density 
in the PEG group was the highest compared to the other groups 
(Figure 4). This was probably caused by the mild local inflamma-
tion or immune response caused by PEG hydrogel delivery.
In addition to angiogenesis, local inflammation after 
hydrogel treatment is also vital to skin flap regeneration. 
Immunohistochemical staining for CD68 was performed in 
order to assess the effect of MF-Lip@PEG on skin flap inflam-
mation during the regeneration process. As shown in Figure 4, 
the CD68 staining in the PEG group was significantly higher 
than that in the MF-Lip, MF-Lip@PEG and control groups. The 
average macrophage density was 50 ± 19 cells per spot in the 
control group and 244 ± 10 cells per spot in the PEG group. 
The average macrophage density was 120 ± 9 cells per spot 
in the 40 × 10−6 m MF-Lip group. Additionally, CD68 staining 
decreased as the concentration of MF-Lip@PEG increased. 
The average macrophage densities were 199 ± 15 cells per 
spot in the MF-Lip10@PEG group; 145 ± 20 cells per spot 
in the MF-Lip20@PEG group; and 107 ± 12 cells per spot 
in the MF-Lip40@PEG group. The results showed that the 
MF-Lip@PEG could alleviate the mild local inflammatory 
reaction.
Hydrogels, as foreign bodies, usually give rise to the mild 
local inflammatory reaction. This response could cause reactive 
neovascularization, which is beneficial for skin flap regen-
eration (Figure 4). However, excessive and persistent inflam-
mation is not beneficial to flap recovery. However, the above 
Figure 3. The skin flap survival rates after treatment. a) A random skin flap animal model, in which the flap was 1.5 cm (width) × 5 cm (length) on 
the rats’ dorsal side with the pedicle at the tail end. b,c) After flap elevation, 0.3 mL of hydrogel solution was intradermally injected into the flap skin, 
and the hydrogel was injected evenly into the flap at 20 dots for each flap (yellow arrow). d) Flap necrosis area percentages of different groups; e, first 
row): the laser speckle contrast imaging captured real-time blood flow images of different groups. e, second row): photos of skin flaps in different 
groups; e, third row), H&E staining of the necrosis and survival junction area of the skin flaps in different groups. e, last row), Magnified view of the 
survival area in different groups. *p < 0.05.
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results showed that the skin flap 
distal end survival rate was signifi-
cantly increased in the PEG group 
compared to the control group. 
This finding indicates that PEG 
may cause mild inflammation in 
the flap tissue but does not affect 
the skin flap survival rate.
The MF-Lip@PEG is dynamic 
coordinative hydrogel that is formed 
by four-arm-PEG-SH and Ag+ Ag–S 
coordination. During hydrogel deg-
radation, the MF-Lip@PEG can 
slowly release Ag+ into the skin 
flap. To explore the antibacterial 
ability of the hydrogel, Staphylo-
coccus aureus immunofluorescence 
staining was performed. As shown 
in Figure 4b, compared to the 
control (39 ± 4 bacteria per spot), 
40 × 10−6 m MF-Lip (20 ± 3 bacteria 
per spot) showed an outstanding 
antibacterial property. The 
S. aureus bacteria numbers could 
be further decreased by treatment 
with the MF-Lip10@PEG (15 ± 2 
bacteria per spot), MF-Lip20@PEG 
(13 ± 3 bacteria per spot), and 
MF-Lip40@PEG (8 ± 2 bacteria per 
spot). This result significantly dem-
onstrates the effective antibacterial 
property of the MF-Lip@PEG.
Bacterial infection is another 
leading cause of random skin 
flap necrosis, as flap tissues are 
especially vulnerable in an early 
stage hypoxic environment. Ag+ 
is a well-known antibacterial 
agent and has long been used 
for targeted therapy of wound 
bacterial infections to promote 
wound healing.[37,38] However, 
excessively high concentrations 
of Ag+ irons in the early stage of 
wound healing can damage the 
tissue cells and induce innate 
cell apoptosis. The MF-Lip@PEG 
in vitro release and degradation 
characteristics (Figure 1) indi-
cate that dense network of the 
MF-Lip@PEG could retard the 
drug release rate and ensure 
Figure 4. Effect of MF-Lip@PEG on random-pattern skin flap neovascularization, inflammation, and 
infection. Immunohistochemical images of flaps highlighting a) blood vessel CD31-positive endothelial 
cells (red dots mark the microvessels) and CD68-positive macrophage/monocytes (red arrows mark the 
cells). b) Immunofluorescence images 
of flaps highlighting S. aureus (green). 
The c) average microvessel densities, 
the d) average macrophage densities 
and b) the average bacterial densities in 
different groups. *p < 0.05.
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prolonged degradation during the endurance period. This 
behavior leads to constant but more favorable release concen-
trations of Ag+ for accelerating skin flap healing. The number 
of S. aureus bacteria in the PEG group was 55 ± 5 bacteria per 
spot, higher than that in the control (39 ± 4 bacteria per spot) 
group and the rest of the hydrogel treatment groups. This 
result suggests that PEG and the other hydrogels used for the 
skin flap are potential infection sources, which may induce 
local tissue inflammation (as observed in Figure 4a) and infec-
tions. However, the MF-Lip@PEG could significantly reverse 
the flap bacterial number, which was in accordance with the 
reverse of the flap inflammation results observed upon treat-
ment with the MF-Lip@PEG (Figure 4a). From these results, 
it was observed that MF-Lip@PEG possessed an outstanding 
antibacterial ability.
In summary, we have developed a hydrogel consisting of 
multifunctional four-arm-PEG crosslinked with Ag+ and loaded 
with MF-Lip. The MF-Lip@PEG was injectable and had self-
healing properties, low swelling percentages, a long endurance 
period, and excellent drug dispersibility and release charac-
teristics for prolonged drug delivery. In addition, the hydrogel 
possessed the distinctive functions of the combined effects 
of PEG, Ag+ and MF-Lip. The in vitro study results demon-
strated that the MF-Lip@PEG exhibited an outstanding proan-
giogenic effect and a strong protective effect on cells against 
hypoxia-induced apoptosis through regulation of the Bax/Bcl-2/
caspase-3 pathway. The in vivo study demonstrated that the 
MF-Lip@PEG promoted skin flap angiogenesis, decreased skin 
flap inflammation, reduced skin flap infection, and significantly 
enhanced the skin flap survival rate. Overall, the injectable mul-
tifunctional MF-Lip@PEG holds great promise for effectively 
matching the renewal of tissue regeneration.
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